MDCX יחס מהיר Medicus Pharma Ltd.

The price action chart for Medicus Pharma Ltd. (MDCX) reflects a quick ratio of 1.55. Medicus Pharma Ltd. (MDCX) is implementing innovative patches for the painless treatment of eczema and psoriasis. The business relies on joint drug trials for skin tumors conducted with clinics. Sustainable development is ensured by a strong staff of oncologists and the recruitment of specialized managers through a stock option system.

For an investor in Medicus Pharma Ltd. (MDCX), the company's ability to fund the transition from surgical methods to innovative microneedle patches without incurring expensive debt is critical. By analyzing the quick ratio on GURU.Markets, you assess the issuer's ability to meet its obligations using only cash and accounts receivable, completely excluding illiquid inventories from the calculation.